These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 21262769)

  • 1. CCN5, a novel transcriptional repressor of the transforming growth factor β signaling pathway.
    Sabbah M; Prunier C; Ferrand N; Megalophonos V; Lambein K; De Wever O; Nazaret N; Lachuer J; Dumont S; Redeuilh G
    Mol Cell Biol; 2011 Apr; 31(7):1459-69. PubMed ID: 21262769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular cloning and characterization of the human WISP-2/CCN5 gene promoter reveal its upregulation by oestrogens.
    Fritah A; Redeuilh G; Sabbah M
    J Endocrinol; 2006 Dec; 191(3):613-24. PubMed ID: 17170219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocorticoids induce CCN5/WISP-2 expression and attenuate invasion in oestrogen receptor-negative human breast cancer cells.
    Ferrand N; Stragier E; Redeuilh G; Sabbah M
    Biochem J; 2012 Oct; 447(1):71-9. PubMed ID: 22765757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor induces WISP-2/CCN5 expression in estrogen receptor-alpha-positive breast tumor cells through multiple molecular cross-talks.
    Banerjee S; Sengupta K; Saxena NK; Dhar K; Banerjee SK
    Mol Cancer Res; 2005 Mar; 3(3):151-62. PubMed ID: 15798095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing of the transforming growth factor-beta (TGFbeta) receptor II by Kruppel-like factor 14 underscores the importance of a negative feedback mechanism in TGFbeta signaling.
    Truty MJ; Lomberk G; Fernandez-Zapico ME; Urrutia R
    J Biol Chem; 2009 Mar; 284(10):6291-300. PubMed ID: 19088080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elucidating the mechanism of regulation of transforming growth factor β Type II receptor expression in human lung cancer cell lines.
    Halder SK; Cho YJ; Datta A; Anumanthan G; Ham AJ; Carbone DP; Datta PK
    Neoplasia; 2011 Oct; 13(10):912-22. PubMed ID: 22028617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gain of oncogenic function of p53 mutants induces invasive phenotypes in human breast cancer cells by silencing CCN5/WISP-2.
    Dhar G; Banerjee S; Dhar K; Tawfik O; Mayo MS; Vanveldhuizen PJ; Banerjee SK
    Cancer Res; 2008 Jun; 68(12):4580-7. PubMed ID: 18559502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCN2 and CCN5 exerts opposing effect on fibroblast proliferation and transdifferentiation induced by TGF-β.
    Xu H; Li P; Liu M; Liu C; Sun Z; Guo X; Zhang Y
    Clin Exp Pharmacol Physiol; 2015 Nov; 42(11):1207-19. PubMed ID: 26218313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon consensus sequence-binding protein (ICSBP) promotes epithelial-to-mesenchymal transition (EMT)-like phenomena, cell-motility, and invasion via TGF-β signaling in U2OS cells.
    Sung JY; Park SY; Kim JH; Kang HG; Yoon JH; Na YS; Kim YN; Park BK
    Cell Death Dis; 2014 May; 5(5):e1224. PubMed ID: 24832596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of WISP-2/CCN5 in the maintenance of a differentiated and noninvasive phenotype in human breast cancer cells.
    Fritah A; Saucier C; De Wever O; Bracke M; Bièche I; Lidereau R; Gespach C; Drouot S; Redeuilh G; Sabbah M
    Mol Cell Biol; 2008 Feb; 28(3):1114-23. PubMed ID: 18070926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restoration of transforming growth factor-beta signaling through receptor RI induction by histone deacetylase activity inhibition in breast cancer cells.
    Ammanamanchi S; Brattain MG
    J Biol Chem; 2004 Jul; 279(31):32620-5. PubMed ID: 15155736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leptin-induced ER-α-positive breast cancer cell viability and migration is mediated by suppressing CCN5-signaling via activating JAK/AKT/STAT-pathway.
    Haque I; Ghosh A; Acup S; Banerjee S; Dhar K; Ray A; Sarkar S; Kambhampati S; Banerjee SK
    BMC Cancer; 2018 Jan; 18(1):99. PubMed ID: 29370782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor-beta inhibits pulmonary surfactant protein B gene transcription through SMAD3 interactions with NKX2.1 and HNF-3 transcription factors.
    Li C; Zhu NL; Tan RC; Ballard PL; Derynck R; Minoo P
    J Biol Chem; 2002 Oct; 277(41):38399-408. PubMed ID: 12161428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The transcription factors Snail and Slug activate the transforming growth factor-beta signaling pathway in breast cancer.
    Dhasarathy A; Phadke D; Mav D; Shah RR; Wade PA
    PLoS One; 2011; 6(10):e26514. PubMed ID: 22028892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of transforming growth factor-β signaling promotes collective cancer cell invasion through tumor-stromal crosstalk.
    Matise LA; Palmer TD; Ashby WJ; Nashabi A; Chytil A; Aakre M; Pickup MW; Gorska AE; Zijlstra A; Moses HL
    Breast Cancer Res; 2012 Jul; 14(4):R98. PubMed ID: 22748014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homeoprotein Six1 increases TGF-beta type I receptor and converts TGF-beta signaling from suppressive to supportive for tumor growth.
    Micalizzi DS; Wang CA; Farabaugh SM; Schiemann WP; Ford HL
    Cancer Res; 2010 Dec; 70(24):10371-80. PubMed ID: 21056993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasohibin-2 is required for epithelial-mesenchymal transition of ovarian cancer cells by modulating transforming growth factor-β signaling.
    Norita R; Suzuki Y; Furutani Y; Takahashi K; Yoshimatsu Y; Podyma-Inoue KA; Watabe T; Sato Y
    Cancer Sci; 2017 Mar; 108(3):419-426. PubMed ID: 28064471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WISP-2/CCN5 is involved as a novel signaling intermediate in phorbol ester-protein kinase Calpha-mediated breast tumor cell proliferation.
    Sengupta K; Banerjee S; Dhar K; Saxena NK; Mehta S; Campbell DR; Banerjee SK
    Biochemistry; 2006 Sep; 45(35):10698-709. PubMed ID: 16939222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of FXYD3 is induced by transforming growth factor-β signaling via ZEB1/δEF1 in human mammary epithelial cells.
    Yamamoto H; Mukaisho K; Sugihara H; Hattori T; Asano S
    Biol Pharm Bull; 2011; 34(3):324-9. PubMed ID: 21372379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of WISP-2/CCN5 signaling in human pancreatic cancer: a potential mechanism for epithelial-mesenchymal-transition.
    Dhar G; Mehta S; Banerjee S; Gardner A; McCarty BM; Mathur SC; Campbell DR; Kambhampati S; Banerjee SK
    Cancer Lett; 2007 Aug; 254(1):63-70. PubMed ID: 17383817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.